The Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA), supported by the Bristol Myers Squibb Foundation, is a 2-year program designed to support the career development of early-stage investigator (as defined by NIH) physicians from diverse backgrounds, and physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring. Currently, our clinical research areas include cancer, cardiovascular disease and immunologic disorders.
The Winn CDA offers a comprehensive and integrated approach to increasing diversity in clinical trials through workforce development and mentoring.
The Winn CDA provides $120,000 annually for two years to institutions sponsoring scholars. The funds are expected to cover a percentage of each scholar’s salary, equivalent to 40% of their time. Scholars are required to receive mentorship from a seasoned clinical investigator at a clinical trial site or institution and are expected to actively participate in their mentor’s clinical trial, which must meet the FDA Clinical Trial Definition. Scholars aren’t expected to run their own trials.